R&D, Pharmacovigilance & Regulatory Affairs
R&D, Pharmacovilance & Regulatory Affairs
Researching, developing, testing and launching new drug solutions. The development process lasts from 8 to 10 years and is made up of 4 phases.
Title
|
Location | Date | Req ID | |
|---|---|---|---|---|
|
Specialist Care Therapeutic Area, Global Regulatory Affairs and Patient Safety - Temporary
Paris, Bois Colombes, FR
Jul 7, 2026
7450
|
||||
|
Specialist, Labelling & Compliance Regulatory Affairs, Global Rare Diseases
Parma, IT
Jul 11, 2026
7364
|
||||